Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: A meta-analysis of unconfounded studies

British Journal of Surgery

Volumn 85, Issue 2, 1998, Pages 171-178

  McAlister, F A ^a   Clark, H D ^a   Wells, P S ^a   Laupacis, A ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER PATIENT; CANCER RECURRENCE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

BLOOD TRANSFUSION; COHORT STUDIES; HUMANS; INFECTION; INTRAOPERATIVE CARE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031888193     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1998.00698.x     Document Type: Article

References (83)

1. Freidman BA, Burns TL, Schork MA. A study of blood utilisation by diagnosis, month of transfusion, and geographic region of the United States. Transfusion 1979; 19: 511-25.
2. Chiavetta JA, Herst R, Freedman J, Axcell TJ, Wall AJ, van Rooy SC. A survey of red cell use in 45 hospitals in central Ontario, Canada. Transfusion 1996; 36: 699-706.
3. Francis DMA. Relationship between blood transfusion and tumour behaviour. Br J Surg 1991; 78: 1420-8.
4. Hallissey MT, Crowson MC, Kiff RS, Kingston RD, Fielding JWL. Blood transfusion: an overused resource in colorectal cancer surgery. Ann R Coll Surg Engl 1992; 74: 59-62.
5. Friedman BA, Burns TL, Schork MA, Kalton G. A description and analysis of current blood transfusion practices in the United States with applications for the hospital transfusion committee. In: Homburger HA, Batsakis JG, eds. Clinical Laboratory Annual. Vol. 1. New York: Appleton-Century-Crofts, 1982: 147-69.
6. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer cell activity in recipients of repeated blood transfusions. Blood 1984; 64: 308-10.
7. Gafter U, Kalechman Y, Sredni B. Induction of a subpopulation of suppressor cells by a single blood transfusion. Kidney Int 1992; 41: 143-8.
8. Opelz G, Sengar DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253-9.
9. Peters WR, Fry RD, Fleshman JW, Kodner IJ. Multiple blood transfusions reduce the recurrence rate of Crohn's disease. Dis Colon Rectum 1989; 32: 749-53.
10. Gantt CL. Red blood cells for cancer patients. Lancet 1981; ii: 363 (Letter).
11. Vamvakas EC, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion 1993; 33: 754-65.
12. Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion 1995; 35: 760-8.
13. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 1993; 80: 427-32.
14. Duffy G, Neal KR. Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion - a meta analysis of published randomized and nonrandomized studies. Transfus Med 1996; 6: 325-8.
15. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion 1996; 36: 175-86.
16. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995; 82: 582-7.
17. Nathanson SD, Tilley BC, Schultz L, Smith RF. Perioperative allogeneic blood transfusions. Survival in patients with resected carcinomas of the colon and rectum. Arch Surg 1985; 120: 734-8.
18. Mikulin T, Powell CS, Urwin GH, Hamdy F, Fox M, Williams HL. Relation between blood transfusion and survival in renal adenocarcinoma. Br J Surg 1986; 73: 1036-7 (Abstract).
19. Blumberg N, Agarwal MM, Chuang C. Relation between recurrence of cancer of the colon and blood transfusion. BMJ 1985; 290: 1037-9.
20. Miettinen AS. The need for randomization in the study of intended effects. Stat Med 1983; 2: 267-71.
21. Blajchman MA, Bordin JO. Mechanisms of transfusion-associated immunosuppression. Curr Opin Hematol 1994; 1: 457-61.
22. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84: 1703-21.
23. Persijn GG, Cohen B, Lansbergen Q, van Rood JJ. Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The Netherlands. Transplantation 1979; 28: 396-401.
24. Singh SK, Marquet RL, de Bruin RWF, Westbroek DL, Jeekel J. Promotion of tumour growth by blood transfusions. Transplant Proc 1987; 19: 1473-4.
25. Jensen LS, Andersen AJ, Christiansen PM et al. Post-operative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 513-16.
26. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996; 17: 1-12.
27. Levine M, Walter S, Lee H et al. for the Evidence-Based Medicine Working Group. Users' guides to the medical literature. IV. How to use an article about harm. JAMA 1994; 271: 1615-19.
28. Hoynck van Papendrecht MAW, Hop W, Langenhorst BLAM, Kothe FC, Marquet RL, Jeekel J. Feasibility of a predeposit autologous blood donation program in colorectal cancer patients: results from a randomized clinical study. Vox Sang 1992; 62: 102-7.
29. Newman JH, Bowers M, Murphy J. Reduction of postoperative infection by use of autologous reinfusion. Transfusion 1996; 36: 657 (Abstract).
30. van de Watering LM, Houbiers JG, Hermans J et al. Leukocyte depletion reduces postoperative mortality in patients undergoing cardiac surgery. Proceedings of the 24th Congress of the International Society of Blood Transfusion, Mukuhar, Japan, 1996: 37 (Abstract).
31. Maeta M, Shimizu N, Oka A et al. Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer. J Surg Oncol 1994; 55: 149-53.
32. Braga M, Vignali A, Radaelli G, Gianotti L, Di Carlo V. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. Eur J Surg 1992; 158: 531-6.
33. Tartter PI, Quintero S, Barron DM. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg 1986; 152: 479-82.
34. Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg 1988; 75: 789-92.
35. Crowe JP, Gordon NH, Fry DE, Shuck JM, Hubay CA. Breast cancer survival and perioperative blood transfusion. Surgery 1989; 106: 836-41.
36. Little AG, Wu HS, Ferguson MK et al. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg 1990; 160: 630-3.
37. Quintiliani L, Buzzonetti A, DiGirolamo M et al. Effects of blood transfusion on the immune responsiveness and survival of cancer patients: a prospective study. Transfusion 1991; 31: 713-18.
38. Eickhoff JH, Andersen J, Laybourn C on behalf of the Danish Breast Cancer Cooperative Group. Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. Br J Surg 1991; 78: 1358-51.
39. Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992; 216: 633-8.
40. Sene A, Jeacock J, Robinson C, Walsh S, Kingston RD. Blood transfusion does not have an adverse effect on survival after operation for colorectal cancer. Ann R Coll Surg Engl 1993; 75: 261-7.
41. Sibbering DM, Locker AP, Hardcastle JD, Armitage NC. Blood transfusion and survival in colorectal cancer. Dis Colon Rectum 1994; 37: 358-63.
42. Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994; 167: 256-60.
43. Harder F, Laffer U, Berres M, Jaggi P, Metzger U. Transfusion sanguine, chimiotherapie intraportale perioperatoire de courte duree et recidive du cancer colorectal. Chirurgie 1989; 115: 759-66.
44. Heslin MJ, Gaynor JJ, Newman E et al. Effect of perioperative blood transfusion on recurrence and survival in 232 primary high-grade extremity sarcoma patients. Ann Surg Oncol 1994; 1: 189-97.
45. Laffer U, Jaggi P, Harder F et al. Bluttransfusionen und die prognose nach kurativer resektion kolorektaler karzinome: besteht eine association? Helv Chir Acta 1989; 56: 461-4.
46. Vente JP, Wiggers T, Weidema WF, Jeekel J, Obertop H. Peri-operative blood transfusions in colorectal cancer. Eur J Surg Oncol 1989; 15: 371-4.
47. Kikuchi K, Narige S, Yamahata K et al. Postoperative follow-up results of patients with non-small cell lung cancer (stage 1) who received autologous blood transfusion. Nippon Kyobu Geka Gakkai Zasshi 1996; 44: 315-16.
48. Garau I, Benito E, Bosch FX et al. Blood transfusion has no effect on colorectal cancer survival. A population-based study. Eur J Cancer 1994; 30A: 759-64.
49. Robbins KT, Favrot S, Hanna D, Cole R. Risk of wound infection in patients with head and neck cancer. Head Neck 1990; 12: 143-8.
50. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165: 68-72.
51. Vignali A, Braga M, Gianotti L et al. A single unit of transfused allogeneic blood increases postoperative infections. Vox Sang 1996; 71: 170-5.
52. Vignali A, Braga M, Dionigi P et al. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer. Eur J Surg 1995; 161: 487-92.
53. von Doersten P, Cruz RM, Selby JV, Hilsinger RL Jr. Transfusion, recurrence, and infection in head and neck cancer surgery. Otolaryngol Head Neck Surg 1992; 106: 60-7.
54. Mezrow CK, Bergstein I, Tartter PI. Postoperative infections following autologous and homologous blood transfusions. Transfusion 1992; 32: 27-30.
55. Blumberg N, Chuang-Stein C, Heal JM. The relationship of blood transfusion, tumor staging, and cancer recurrence. Transfusion 1990; 30: 291-4.
56. Mecklin JP, Jarvinen HJ, Ovaska JT. Blood transfusion and prognosis in colorectal carcinoma. Scand J Gastroenterol 1989; 24: 33-9.
57. Jensen LS, Andersen AJ, Christiansen PM et al. Blood transfusion increases the risk of surgical infection. Ugeskr Laeger 1993; 155: 3263-6.
58. Jensen LS, Hokland M, Nielsen HJ. A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1996; 83: 973-7.
59. Heiss MM, Jauch KW, Delanoff C, Mempel W, Schildberg FW. Blood transfusion modulated tumor recurrence: a randomized study of autologous vs. homologous blood transfusion in colorectal cancer. Proceedings of the Annual Meeting of the American Society of Clinical Oncology 1992; 11: A503 (Abstract).
60. Heiss MM, Mempel W, Delanoff C, Mempel M, Jauch KW, Schildberg FW. Clinical effects of blood transfusion-associated immune modulation on outcome of tumor surgery. Infusionsther Transfusionsmed 1993; 20(Suppl 2): 25-9.
61. Busch ORC, Hop WCJ, Marquet RL, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg 1994; 220: 791-7.
62. Busch ORC, Hop WCJ, Marquet RL, Jeekel J. Prognostic impact of blood transfusions on disease-free survival in colorectal carcinoma. Scand J Gastroenterol 1993; 200(Suppl): 21-3.
63. Busch ORC, Hop WCJ, Marquet RL, Jeekel J. The effect of blood transfusions on survival after surgery for colorectal cancer. Eur J Cancer 1995; 31A: 1226-8.
64. Houbiers JG, van de Velde CJ, van de Watering LM et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997; 37: 126-34.
65. Heiss MM, Mempel W, Jauch KW et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342: 1328-33.
66. Heiss MM, Mempel W, Delanoff C et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859-67.
67. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomized comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348: 841-5.
68. Houbiers JGA, Brand A, van de Watering LMG et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344: 573-8.
69. Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-6.
70. Kajikawa M, Nonami T, Kurokawa T et al. Autologous blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular carcinoma: use of recombinant human erythropoietin. Surgery 1994; 115: 727-34.
71. Ness PM, Walsh PC, Zahurak M, Baldwin ML, Piantadosi S. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood. Transfusion 1992; 32: 31-6.
72. Giurati G, Zanetta G, Caspani L et al. Autologous blood transfusion in patients undergoing radical hysterectomy. Br J Obstet Gynaecol 1995; 102: 64-5.
73. Goodman SN. Have you ever meta-analysis you didn't like? Ann Intern Med 1991; 114: 244-6 (Editorial).
74. Blajchman MA. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet? Transfusion 1997; 37: 121-5.
75. Borzak S, Ridker PM. Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med 1995; 123: 873-7.
76. Spoor P, Airey M, Bennett C, Greensill J, Williams R. Use of the capture-recapture technique to evaluate the completeness of systematic literature searches. BMJ 1996; 313: 342-3.
77. Dickersin K, Min Y-I, Meinert CL. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA 1992; 267: 374-8.
78. Enblad P, Adami HO, Bergstrom R, Glimelius B, Krusemo U, Pahlman L. Improved survival of patients with cancers of the colon and rectum? J Natl Cancer Inst 1988; 80: 586-91.
79. Roncucci L, Fante R, Losi L et al. Survival for colon and rectal cancer in a population-based cancer registry. Eur J Cancer 1996; 32A: 295-302.
80. Wallace EL, Churchill WH, Surgenor DM et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995; 35: 802-12.
81. Etchason J, Petz L, Keeler E et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995; 332: 719-24.
82. Forgie M, Wells P, Laupacis A, Fergusson D for the ISPOT investigators. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red cell transfusion: results of a meta-analysis. Arch Intern Med 1998 (in press).
83. Cohen JA, Brecher ME. Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion 1995; 35: 640-4.